---
title: 'The impact of botanical fermented foods on metabolic syndrome and type 2 diabetes:
  a systematic review of randomised controlled trials'
date: '2023-10-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37881833/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231026180915&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Our systematic review assessed the impact of botanical fermented food
  (BFF) consumption on glucose, lipid, anthropometric, inflammatory and gut microbiota
  parameters, in adults with metabolic syndrome (MetS), MetS components or type 2
  diabetes mellitus (T2DM). Embase, MEDLINE, Cochrane CENTRAL and Google Scholar were
  searched with no language limits, from inception to August 31, 2022, for eligible
  randomised controlled trials (RCTs). Two independent reviewers screened 6873 abstracts
  ...
disable_comments: true
---
Our systematic review assessed the impact of botanical fermented food (BFF) consumption on glucose, lipid, anthropometric, inflammatory and gut microbiota parameters, in adults with metabolic syndrome (MetS), MetS components or type 2 diabetes mellitus (T2DM). Embase, MEDLINE, Cochrane CENTRAL and Google Scholar were searched with no language limits, from inception to August 31, 2022, for eligible randomised controlled trials (RCTs). Two independent reviewers screened 6873 abstracts ...